We are a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

Click on the link below for our latest corporate presentation.

Clinical Trials Information

Resources and guides for patients and caregivers.

Click on the link below for more information.

Latest News

MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
Read More

MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
Read More

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close